Core Viewpoint - Lear (LEA) is expected to report quarterly earnings of $3.23 per share, reflecting a decline of 10.3% year-over-year, with revenues forecasted at $5.89 billion, a decrease of 2% compared to the previous year [1] Earnings Projections - Changes in earnings projections are crucial for predicting investor reactions to the stock, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [2] Analysts' Consensus on Key Metrics - Analysts forecast 'Net Sales- E-Systems' to be $1.52 billion, indicating a year-over-year decline of 2.9% [4] - 'Net Sales- Seating' is projected to reach $4.37 billion, reflecting a decrease of 1.7% from the same quarter last year [4] - 'Geographic Net Sales- South America' is expected to be $235.04 million, showing an increase of 9.9% year-over-year [4] - 'Geographic Net Sales- North America' is estimated at $2.44 billion, indicating a decline of 4.6% [5] - 'Geographic Net Sales- Europe and Africa' is projected to be $2.13 billion, reflecting a decrease of 1.8% [5] - 'Geographic Net Sales- Asia' is expected to reach $1.13 billion, indicating an increase of 5.4% from the prior year [5] Adjusted Segment Earnings - 'Adjusted Segment Earnings- E-Systems' is estimated at $66.73 million, down from $82.20 million in the same quarter last year [6] - 'Adjusted Segment Earnings- Seating' is projected to be $276.06 million, compared to $302.10 million in the previous year [6] Stock Performance - Shares of Lear have increased by 14.4% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.9% [6]

Core Insights - IBM is expected to report quarterly earnings of $2.64 per share, reflecting an 8.6% increase year-over-year, with revenues projected at $16.58 billion, indicating a 5.1% year-over-year growth [1]. Earnings Projections - There has been a downward revision of 0.2% in the consensus EPS estimate over the last 30 days, indicating analysts' reassessment of their forecasts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts predict 'Revenue- Infrastructure' to reach $3.66 billion, a 0.3% increase from the previous year [5]. - 'Revenue- Software' is expected to be $7.48 billion, reflecting an 11% year-over-year increase [5]. - 'Revenue- Consulting' is forecasted at $5.21 billion, indicating a 0.6% increase year-over-year [5]. - 'Revenue- Hybrid Infrastructure' is estimated at $2.39 billion, showing a 0.6% decline from the prior year [6]. - 'Revenue- Transaction Processing' is projected to be $2.28 billion, reflecting a 3.8% increase year-over-year [6]. - 'Revenue- Infrastructure Support' is expected to be $1.25 billion, indicating a 3.7% decline year-over-year [6]. - 'Revenue- Other' is estimated at $51.29 million, suggesting a significant 35% year-over-year increase [7]. Gross Profit Estimates - 'Gross Profit- Consulting' is expected to be $1.37 billion, slightly up from $1.36 billion reported in the same quarter last year [7]. - 'Gross Profit- Infrastructure' is projected at $2.01 billion, down from $2.06 billion reported in the previous year [8]. - 'Gross Profit- Software' is expected to reach $6.25 billion, up from $5.63 billion reported in the same quarter last year [8]. Market Performance - IBM shares have shown a return of -0.4% over the past month, contrasting with the Zacks S&P 500 composite's +5.4% change, indicating potential underperformance in the near future [8].

Core Insights - Analysts expect Fiserv (FI) to report quarterly earnings of $2.42 per share, reflecting a year-over-year increase of 13.6% [1] - Revenue projections for Fiserv stand at $5.2 billion, indicating an 8.5% increase from the same quarter last year [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, suggesting stability in analysts' forecasts [1] Revenue Projections - The 'Revenue- Processing and services' is anticipated to reach $4.45 billion, representing a 7.6% increase from the prior-year quarter [4] - The 'Revenue- Product' is expected to be $1.06 billion, indicating a year-over-year change of 9.6% [4] - The 'Adjusted Revenue- Corporate and Other' is projected at $5.25 million, reflecting a 5% increase from the previous year [4] Stock Performance - Over the past month, Fiserv shares have returned +3.7%, compared to the Zacks S&P 500 composite's +5.4% [5] - Fiserv holds a Zacks Rank 3 (Hold), suggesting that its performance is likely to align with the overall market in the near term [5]

Core Insights - Intuit (INTU) is expected to report quarterly earnings of $10.89 per share, reflecting a 10.2% increase year over year, with revenues forecasted at $7.54 billion, a 12% year-over-year increase [1] Revenue Projections - Analysts estimate 'Net revenue- Consumer' to reach $3.97 billion, indicating an 8.6% year-over-year change [4] - 'Net revenue- Small Business & Self-Employed' is projected at $2.86 billion, suggesting a 20% increase from the previous year [4] - 'Net revenue- Credit Karma' is expected to be $430.66 million, reflecting a decrease of 2.8% year over year [4] - 'Net revenue- ProTax' is forecasted at $273.84 million, indicating a 7.8% year-over-year increase [5] - 'Net revenue- Small Business & Self-Employed- Total Online Ecosystem' is projected to be $2.14 billion, suggesting a 22.2% increase from the prior year [5] - 'Net revenue- Small Business & Self-Employed- Total Desktop Ecosystem' is expected to reach $723.63 million, reflecting a 14.3% year-over-year change [6] - 'Net revenue- Small Business & Self-Employed- Online Ecosystem- QuickBooks Online Accounting' is projected at $1.06 billion, indicating a 22.9% increase [6] - 'Net revenue- Small Business & Self-Employed- Desktop Ecosystem- Desktop Services and Supplies' is estimated at $309.72 million, suggesting a 4.6% year-over-year change [7] - 'Net revenue- Small Business & Self-Employed- Online Ecosystem- Online Services' is expected to be $1.08 billion, reflecting a 20.5% increase [7] - 'Net revenue- Small Business & Self-Employed- Desktop Ecosystem- QuickBooks Desktop Accounting' is projected at $411.32 million, indicating a 22.1% increase [8] - 'Net revenue- Service' is expected to reach $6.67 billion, suggesting a 10.3% year-over-year change [8] - 'Net revenue- Product and other' is forecasted at $770.35 million, indicating an 11.8% year-over-year increase [9] Stock Performance - Over the past month, Intuit shares have returned +14.5%, outperforming the Zacks S&P 500 composite's +13.1% change [10]

Core Insights - TEGNA Inc. (TGNA) is expected to report quarterly earnings of $0.34 per share, reflecting a year-over-year decline of 24.4% [1] - Projected revenues for TEGNA are $677.17 million, down 5.2% from the same quarter last year [1] - Analysts have revised their consensus EPS estimate downward by 5.6% over the past 30 days, indicating a reassessment of initial projections [1] Revenue Breakdown - 'Revenues- Political' are estimated to reach $5.30 million, indicating a significant year-over-year decline of 81% [4] - 'Revenues- Subscription' are projected at $367.46 million, reflecting a decrease of 2.1% from the prior year [4] - 'Revenues- Advertising & Marketing Services' are expected to be $291.96 million, showing a decline of 2.3% year-over-year [4] - 'Revenues- Other' are anticipated to reach $12.45 million, suggesting a slight increase of 0.3% year-over-year [5] Market Performance - TEGNA shares have increased by 4.8% over the past month, compared to a 10.6% increase in the Zacks S&P 500 composite [6] - TEGNA holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [6]

With that in mind, let's delve into the average projections of some Haemonetics metrics that are commonly tracked and projected by analysts on Wall Street. Wall Street analysts expect Haemonetics (HAE) to post quarterly earnings of $1.22 per share in its upcoming report, which indicates a year-over-year increase of 35.6%. Revenues are expected to be $327.34 million, down 4.7% from the year-ago quarter. The consensus EPS estimate for the quarter has undergone a downward revision of 3.3% in the past 30 days, ...

Wall Street analysts forecast that Epam (EPAM) will report quarterly earnings of $2.27 per share in its upcoming release, pointing to a year-over-year decline of 7.7%. It is anticipated that revenues will amount to $1.28 billion, exhibiting an increase of 10.1% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 5.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their ...

Group 1 - The AZEK Company is expected to report quarterly earnings of $0.44 per share, reflecting a 12.8% increase year over year [1] - Analysts forecast revenues of $443.6 million, indicating a 6% year-over-year growth [1] - There has been no revision in the consensus EPS estimate for the quarter over the past 30 days, suggesting stability in analysts' projections [1] Group 2 - Analysts project 'Net Sales- Commercial' to reach $15.07 million, a decrease of 5% from the prior-year quarter [4] - The estimated 'Net Sales- Residential' is $431.37 million, representing a 7.2% increase year over year [4] - The average prediction for 'Adjusted EBITDA- Residential' is $119.21 million, up from $110.39 million in the previous year [4] Group 3 - Shares of The AZEK Company have increased by 8.1% in the past month, outperforming the Zacks S&P 500 composite, which moved up by 0.4% [5] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the overall market in the near future [5]

Core Viewpoint - Nutrien (NTR) is expected to report a quarterly earnings per share (EPS) of $0.33, reflecting a 28.3% decline year-over-year, with revenues forecasted at $5.32 billion, a decrease of 1.2% from the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.5% higher in the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock performance [3]. Sales and Revenue Projections - Analysts predict 'Sales- Retail Total' to reach $3.49 billion, marking a 5.6% increase from the year-ago quarter [4]. - 'Sales- Nitrogen' is expected to be $972.08 million, down 5.4% year-over-year [5]. - 'Sales- Potash' is forecasted at $783.90 million, indicating a 15.4% decline from the prior year [5]. - 'Sales- Phosphate' is estimated at $435.19 million, reflecting a 12.8% decrease from the previous year [5]. Volume and Pricing Estimates - 'Tonnes Sold - Potash - Total' is projected at 3,255.30 KTon, down from 3,413 KTon year-over-year [6]. - 'Tonnes Sold - Nitrogen' is expected to be 2,473.23 KTon, slightly down from 2,507 KTon [6]. - The average selling price for 'Phosphate - Industrial and feed' is estimated at $777.80 per tonne, down from $848 per tonne in the same quarter last year [7]. - The average selling price for 'Phosphate - Total' is projected at $614.19 per tonne, compared to $689 per tonne a year ago [7]. - 'Average Selling Price per Tonne - Nitrogen - Solutions, nitrates and sulphates' is expected to be $220.56 per tonne, down from $226 per tonne [8]. - 'Average Selling Price per Tonne - Nitrogen - Urea and ESN' is estimated at $410.89 per tonne, compared to $432 per tonne last year [8]. - 'Average Selling Price per Tonne - Nitrogen - Ammonia' is forecasted at $417.19 per tonne, slightly up from $403 per tonne [9]. - 'Tonnes Sold - Phosphate' is expected to be 569.00 KTon, down from 620 KTon in the same quarter last year [9]. Stock Performance - Over the past month, Nutrien shares have returned +11.9%, while the Zacks S&P 500 composite has seen a -0.5% change [9]. - Nutrien currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [10].

Core Viewpoint - Cencora (COR) is expected to report quarterly earnings of $4.08 per share, reflecting a 7.4% increase year-over-year, with revenues projected at $74.82 billion, indicating a 9.4% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised upward by 0.2% in the last 30 days, showcasing analysts' reassessment of their initial projections [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts estimate 'Revenue- Total International Healthcare Solutions' at $7.36 billion, a year-over-year increase of 3.3% [5]. - The consensus for 'Revenue- Total U.S. Healthcare Solutions' is $67.56 billion, reflecting a 10.2% increase from the same quarter last year [5]. - 'Revenue- International Healthcare Solutions- Alliance Healthcare' is projected to reach $5.98 billion, indicating a 3.9% year-over-year change [6]. - 'Revenue- U.S. Healthcare Solutions- Animal Health' is expected to be $1.49 billion, suggesting a 14.1% increase year-over-year [6]. - 'Revenue- U.S. Healthcare Solutions- Human Health' is forecasted at $65.56 billion, reflecting a 9.3% year-over-year growth [6]. - 'Revenue- International Healthcare Solutions- Other Healthcare Solutions' is estimated at $1.42 billion, indicating a 3.8% increase from the previous year [7]. Operating Income Estimates - Analysts project 'Operating income- Non-GAAP- International Healthcare Solutions' to be $182.43 million, down from $192.72 million reported in the same quarter last year [7]. - 'Operating income- Non-GAAP- U.S. Healthcare Solutions' is expected to reach $926.36 million, compared to $841.06 million from the previous year [8]. Stock Performance - Over the past month, Cencora shares have returned +0.4%, outperforming the Zacks S&P 500 composite, which recorded a -0.5% change [8].